AI Engines For more Details: Perplexity Kagi Labs You
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Allergies | 0.5 | 0 | 0 |
| Allergy to milk products | 0 | 0 | |
| Alzheimer's disease | 0.5 | 0.5 | 0 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 0 | 0 |
| Ankylosing spondylitis | 0.5 | 0 | 0 |
| Anorexia Nervosa | 0 | 0 | |
| Asthma | 0 | 0 | 0 |
| Atherosclerosis | 0.8 | 0.8 | |
| Atrial fibrillation | 0.5 | -0.5 | |
| Autism | 0.5 | 1 | -1 |
| Autoimmune Disease | 0.5 | 0.5 | |
| benign prostatic hyperplasia | 0.5 | 0.5 | |
| Biofilm | 1 | 1 | |
| Bipolar Disorder | 0.5 | 0.5 | |
| Brain Trauma | 0.5 | 0.5 | |
| Celiac Disease | 0 | 0 | 0 |
| Chronic Kidney Disease | 0.5 | 0.5 | |
| Chronic Lyme | 0 | 0 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0 | 0 | |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | |
| Colorectal Cancer | 1 | 1 | |
| Constipation | 0.5 | 0.5 | |
| Coronary artery disease | 0.5 | 0.5 | |
| COVID-19 | 0.5 | 0.5 | |
| Crohn's Disease | 1.3 | 1.3 | |
| cystic fibrosis | 0 | 0 | |
| deep vein thrombosis | 0.8 | 0.8 | |
| Depression | 0.5 | 0.5 | 0 |
| Eczema | 0.5 | 0.5 | |
| Endometriosis | 0.5 | 0.5 | |
| Epilepsy | 0.5 | 0.5 | |
| erectile dysfunction | 0.5 | 0.5 | |
| Functional constipation / chronic idiopathic constipation | 0.5 | 0.5 | |
| gallstone disease (gsd) | 0.5 | 0.5 | |
| Generalized anxiety disorder | 0.5 | 0.5 | |
| Gout | 0 | 0.5 | 0 |
| Graves' disease | 0 | 0 | |
| Heart Failure | 0.5 | 0.5 | |
| Hidradenitis Suppurativa | 0.5 | 0.5 | |
| High Histamine/low DAO | 0.8 | 0.8 | |
| hyperglycemia | 0.5 | 0.5 | |
| hypertension (High Blood Pressure | 0.5 | 0.5 | |
| Hypothyroidism | 0.3 | 0.3 | |
| Hypoxia | 0.5 | 0.5 | |
| IgA nephropathy (IgAN) | 0 | 0 | |
| Inflammatory Bowel Disease | 1.6 | 1.6 | |
| Irritable Bowel Syndrome | 0.8 | 0.8 | |
| ischemic stroke | 0.5 | -0.5 | |
| Liver Cirrhosis | 0 | 0 | |
| Long COVID | 0.3 | 0.3 | |
| Lung Cancer | 0.5 | 0.5 | |
| Lymphoma | 0.5 | 0.5 | |
| Mast Cell Issues / mastitis | 0.5 | 0.5 | |
| Metabolic Syndrome | 0.5 | 0.5 | |
| Mood Disorders | 0.5 | 0.5 | 0 |
| Multiple Sclerosis | 0.5 | 0.5 | |
| myasthenia gravis | 0.5 | 0 | 0 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 0.3 | 0.67 |
| Obesity | 1 | 1 | |
| obsessive-compulsive disorder | 0 | 0 | |
| Osteoporosis | 0.5 | 0.5 | |
| pancreatic cancer | 0 | 0 | |
| Parkinson's Disease | 1.3 | 1.3 | |
| Polycystic ovary syndrome | 0.5 | 0.5 | |
| Postural orthostatic tachycardia syndrome | 0 | 0 | |
| Primary sclerosing cholangitis | 0.5 | 0.5 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.3 | 1.3 | |
| Schizophrenia | 0 | 0 | 0 |
| scoliosis | 0.3 | 0.3 | |
| sensorineural hearing loss | 0.5 | 0.5 | |
| Sjögren syndrome | 0.5 | 0.5 | |
| Sleep Apnea | 0.5 | 0.5 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.3 | |
| Stress / posttraumatic stress disorder | 0.5 | 0.5 | |
| Systemic Lupus Erythematosus | 0.5 | 0.5 | |
| Type 1 Diabetes | 0.5 | 0.5 | |
| Type 2 Diabetes | 0.5 | 0.5 | |
| Ulcerative colitis | 1 | 1 | |
| Unhealthy Ageing | 0 | 0 |
